J. Pera

ORCID: 0000-0003-3916-606X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Advanced Radiotherapy Techniques
  • Ocular Oncology and Treatments
  • Breast Cancer Treatment Studies
  • Cutaneous Melanoma Detection and Management
  • Glioma Diagnosis and Treatment
  • Ear and Head Tumors
  • Ocular Infections and Treatments
  • Glaucoma and retinal disorders
  • Health Systems, Economic Evaluations, Quality of Life
  • Breast Lesions and Carcinomas
  • Nonmelanoma Skin Cancer Studies
  • Cancer Treatment and Pharmacology
  • Reconstructive Surgery and Microvascular Techniques
  • Breast Implant and Reconstruction
  • Colorectal and Anal Carcinomas
  • Advanced Breast Cancer Therapies
  • Viral-associated cancers and disorders
  • Lung Cancer Treatments and Mutations
  • Lymphoma Diagnosis and Treatment
  • Endometrial and Cervical Cancer Treatments
  • BRCA gene mutations in cancer
  • Urologic and reproductive health conditions
  • Radiation Therapy and Dosimetry

Institut Català d'Oncologia
2010-2021

Universitat de Barcelona
2009-2021

Institut Català d'Ornitologia
2009-2017

Bellvitge University Hospital
1987-2015

Hospital de Cruces
2015

Dattoli Cancer Center and Brachytherapy Research Institute
2015

Ajuntament de L’Hospitalet
2014

To evaluate efficacy and toxicity after salvage brachytherapy (BT) in prostate local recurrence radiation therapy.Between 1993 2007, we retrospectively analyzed 56 consecutively patients (pts) undergoing brachytherapy. After biopsy-proven recurrence, pts received 145 Gy LDR-BT (37 pts, 66%) or HDR-BT (19 34%) different dose levels according to biological equivalent doses (BED(2 Gy)). By the time of BT, only 15 (27%) ADT. Univariate multivariate analyses were performed identify predictors...

10.1186/1748-717x-9-102 article EN cc-by Radiation Oncology 2014-04-30

The main objective was to study the anatomy of adductor longus by ultrasound and cadaveric dissection, correlate findings with different approaches described, evaluate feasibility defining a "safe window" for interventional musculoskeletal procedures. anatomical performed on six pieces, while evaluations were both lower limbs 26 subjects (n = 52). Ultrasound variables included number saphenous veins, location vein in relation proximal myotendinous junction, vessels within or superficial...

10.1007/s00276-025-03567-2 article EN cc-by Surgical and Radiologic Anatomy 2025-02-07

To evaluate the efficacy of intravitreal dexamethasone implant 0.7 mg (Ozurdex) in radiation maculopathy secondary to plaque brachytherapy choroidal melanoma.Twelve eyes diagnosed and treated with were included. Visual acuity, foveal thickness using spectral domain optical coherence tomography, grade macular edema, Horgan classification, evaluated.Mean age was 65.5 ± 28 years (range, 40-82 years). Mean follow-up 8.2 7.8 months 2-28 months). visual acuity before treatment was, logarithm...

10.1097/iae.0000000000000537 article EN Retina 2015-05-29

The purpose of this study was to demonstrate the existence a bimodal survival pattern in metastatic uveal melanoma. Secondary aims were identify characteristics and prognostic factors associated with long-term develop clinical decision tree.The medical records 99 melanoma patients retrospectively reviewed. Patients classified as either short (≤ 12 months) or survivors (> based on graphical interpretation curve after diagnosis first lesion. Ophthalmic oncological characteristicswere assessed...

10.4143/crt.2017.171 article EN Cancer Research and Treatment 2017-12-03

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Cozzi S, Laplana M, Najjari D, et al. Advantages of intraoperative implant for interstitial brachytherapy accelerated partial breast irradiation either frail patients with early-stage disease or in locally recurrent cancer. Journal Contemporary Brachytherapy. 2018;10(2):97-104. doi:10.5114/jcb.2018.75594. APA Cozzi, S., Laplana, M., Najjari, D., Slocker, A., Encinas, X., & Pera, J. (2018). Brachytherapy, 10(2),...

10.5114/jcb.2018.75594 article EN cc-by-nc-sa Journal of Contemporary Brachytherapy 2018-01-01

Recently, a new classification system for lymphoid neoplasms, known as the REAL classification, has been proposed. Our aim is to know distribution of neoplasms according this schema and compare it with Updated Kiel classification. We also estimate incidence rates in our area. From January 1993 November 1996, 940 patients were diagnosed neoplasm center. Histologic material was prospectively classified both classifications. According all cases follows: 73.6% B-cell neoplasm, 9.4% T-cell 9.6%...

10.1111/j.1600-0609.1997.tb00982.x article EN European Journal Of Haematology 1997-10-01

To assess the 5-year relative survival of patients diagnosed with uveal melanoma (UM) in a single center. UM were recruited from 1995 to 2004 (N = 155) and followed until December 2008. Relative (RS) methods used excess mortality. An RS regression model was fitted by sex, age, tumor origin, treatment, size estimate hazard rate (EHR) death UM. The overall 90%, lower women (84.6%) than men (100%), older 60 years (88.8%) compared those younger or age (94.8%). Large tumors (80.8%) showed medium...

10.1097/cmr.0b013e328353ef30 article EN Melanoma Research 2012-04-19

Lip cancer can be treated by surgery, external radiotherapy, and/or brachytherapy (BT). In recent years, BT has become increasingly favored for this type of cancer. The aim the present study was to analyze local control and survival patients at our institution between July 1989 June 2008.We performed a retrospective 121 (109 males 12 females) who underwent lip from 2008. Median age 67 years median follow-up 31.8 months (range 20-188 months). Out patients, 100 (82.6%) were with low dose rate...

10.5114/jcb.2010.13717 article EN cc-by-nc-sa Journal of Contemporary Brachytherapy 2010-01-01

Objective: To compare the initial costs of three most established treatments for clinically localized prostate cancer according to risk, age and comorbidity groups, from healthcare provider’s perspective. Methods: We carried out a cost comparison study in sample patients consecutively recruited between 2003 2005 functional unit treatment Catalonia (Spain). The use services up 6 months after start date was obtained hospital databases direct were estimated by micro-cost calculation....

10.1016/j.gaceta.2010.10.008 article EN public-domain 2011-01-01

Comparar los costes de tratamientos más establecidos para el cáncer próstata localizado según grupos riesgo, edad y comorbilidad, desde la perspectiva del proveedor asistencial. Comparación en pacientes reclutados consecutivamente entre 2003 2005 una unidad funcional tratamiento próstata. La utilización servicios hasta 6 meses después inicio se obtuvo las bases datos hospitalarias, directos estimaron mediante cálculo microcoste. información sobre características clínicas recogió...

10.1016/j.gaceta.2010.10.008 article ES cc-by-nc-nd Gaceta Sanitaria 2011-01-01

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Gutiérrez C, Najjari D, Martínez E, et al. Original paperThe use of an interstitial boost in the conservative treatment breast cancer: how to perform it routinely a radiotherapy department. Journal Contemporary Brachytherapy. 2014;6(4):397-403. doi:10.5114/jcb.2014.46757. APA Gutiérrez, C., Najjari, D., Martínez, E., Botella, S., Eraso, A., & Pino, F. (2014). Brachytherapy, 6(4), 397-403....

10.5114/jcb.2014.46757 article EN cc-by-nc-sa Journal of Contemporary Brachytherapy 2014-01-01
Coming Soon ...